We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+17.7%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$956M
AUM Growth
-$88.9M
Cap. Flow
-$124M
Cap. Flow %
-13%
Top 10 Hldgs %
51.28%
Holding
904
New
257
Increased
162
Reduced
180
Closed
232

Sector Composition

Rank Sector Weight
1 Healthcare 36.98%
2 Financials 14.53%
3 Materials 10.99%
4 Energy 8.52%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACBAW
601
DELISTED
Ace Global Business Acquisition Ltd Warrant
ACBAW
$1.09K ﹤0.01%
35,169
DLCAW
602
DELISTED
Deep Lake Capital Acquisition Corp. Warrant
DLCAW
$1.08K ﹤0.01%
308,772
+281,840
+1,046% +$3.78K
NOGNW
603
DELISTED
Nogin, Inc. Warrant
NOGNW
$1.07K ﹤0.01%
54,690
BMAQR
604
DELISTED
Blockchain Moon Acquisition Corp. Rights
BMAQR
$1.05K ﹤0.01%
29,080
-10,920
-27% -$820
CLAA.WS
605
DELISTED
Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CLAA.WS
$1.03K ﹤0.01%
20,717
-47,040
-69% -$3.65K
MX icon
606
CALL
Magnachip Semiconductor
MX
$142M
$1.02K ﹤0.01%
+40,800
New +$394K
RGTIW icon
607
Rigetti Computing Warrants
RGTIW
$180M
$1.01K ﹤0.01%
12,499
-12,501
-50% -$2.09K
FHLTW
608
DELISTED
Future Health ESG Corp. Warrant
FHLTW
$1K ﹤0.01%
14,360
+100
+0.7% +$7
SGHLW
609
DELISTED
Signal Hill Acquisition Corp. Warrant
SGHLW
$1K ﹤0.01%
100,366
-85,000
-46% -$3.73K
FXCOW
610
DELISTED
Financial Strategies Acquisition Corp. Warrants
FXCOW
$1K ﹤0.01%
50,000
BLUA.WS
611
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$999 ﹤0.01%
66,665
+49,999
+300% +$1.14K
RJAC.WS
612
DELISTED
Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
RJAC.WS
$994 ﹤0.01%
174,538
-72,362
-29% -$3.1K
JSPRW icon
613
Japer Therapeutics Warrants
JSPRW
$216K
$977 ﹤0.01%
32,590
BSAQ.WS
614
DELISTED
Black Spade Acquisition Co Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BSAQ.WS
$975 ﹤0.01%
19,500
-4,900
-20% -$299
KACLW
615
DELISTED
Kairous Acquisition Corp. Limited Warrants
KACLW
$959 ﹤0.01%
11,850
-8,100
-41% -$408
CSTA.WS
616
DELISTED
Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CSTA.WS
$879 ﹤0.01%
29,326
+15,074
+106% +$381
DHAIW
617
DELISTED
DIH Holding US Inc Warrants
DHAIW
$872 ﹤0.01%
39,500
LMDXW
618
DELISTED
LumiraDx Limited Warrant
LMDXW
$855 ﹤0.01%
+14,495
New +$1.98K
SVFAW
619
DELISTED
SVF Investment Corp. Warrant
SVFAW
$839 ﹤0.01%
+32,415
New +$1.33K
SWSSW
620
DELISTED
Clean Energy Special Situations Corp. Warrant
SWSSW
$836 ﹤0.01%
41,817
+1,917
+5% +$80
ZEOWW
621
Zeo Energy Corp Warrants
ZEOWW
$93.1K
$809 ﹤0.01%
28,290
-25,300
-47% -$1.91K
BMAQW
622
DELISTED
Blockchain Moon Acquisition Corp. Warrants
BMAQW
$805 ﹤0.01%
41,760
KSICW
623
DELISTED
Kadem Sustainable Impact Corporation Warrant
KSICW
$804 ﹤0.01%
78,134
FLDDW
624
Fold Holdings Warrant
FLDDW
$948K
$803 ﹤0.01%
+16,077
New +$907
TWLVW
625
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$797 ﹤0.01%
+50,631
New +$1.34K

Similar funds

Cowen and Company's Q4 2022 Portfolio in Review

As of Q4 2022, Cowen and Company held 904 positions worth $956M, down 8.5% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Cowen and Company withdrew a net $124M in Q4 2022, closing 232 positions and reducing 180 holdings. Its most notable exit was ARK Innovation ETF, an estimated $131M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Financials and Materials.

Against the trend, Cowen and Company opened a new position in DCP Midstream, LP worth $58.8M.

  • Cowen and Company's largest Q4 2022 buy was DCP Midstream, LP: 1,516,562 shares worth $58.8M.
  • Cowen and Company added most to Adicet Bio in Q4 2022, an estimated $10.9M increase.
  • Cowen and Company's biggest Q4 2022 reduction was Immunocore, cutting an estimated $34.1M.
  • Cowen and Company fully exited ARK Innovation ETF in Q4 2022, selling an estimated $131M.
  • Cowen and Company's ten largest holdings make up 51% of its $956M portfolio in Q4 2022.
  • Cowen and Company opened 257 new positions and closed 232 in Q4 2022.
  • Cowen and Company's portfolio value fell 8.5% quarter-over-quarter to $956M.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.